New imaging techniques to identify genetic markers for frontotemporal dementia
Novel imaging genetic biomarkers for sporadic frontotemporal dementia through machine learning
This study is exploring new ways to use advanced imaging and computer technology to find genetic markers that can help diagnose sporadic frontotemporal dementia more accurately, which could lead to better treatment options for patients.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11042834 on NIH RePORTER |
What this research studies
This research focuses on developing advanced imaging techniques combined with machine learning to identify genetic biomarkers associated with sporadic frontotemporal dementia. By utilizing computational modeling and clinical research methodologies, the project aims to improve the accuracy of diagnosing frontotemporal dementia and related conditions. Patients may benefit from enhanced risk prediction and the development of new biomarkers that could lead to better treatment options. The research is led by Dr. Iris Broce-Diaz, who is collaborating with a team of experts in neuroimaging and genetics.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing cognitive decline or symptoms related to frontotemporal dementia or Alzheimer's Disease-Related Dementias.
Not a fit: Patients with other types of dementia or cognitive impairments unrelated to frontotemporal dementia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of frontotemporal dementia, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using machine learning and imaging techniques to identify biomarkers for neurodegenerative diseases, indicating a potential for success in this approach.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Broce-Diaz, Iris J — University of California, San Diego
- Study coordinator: Broce-Diaz, Iris J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.